Delving into the Latest Updates on Dipexium Pharmaceuticals, Inc. with Synapse

概览

关联

2

项与 Dipexium Pharmaceuticals, Inc. 相关的临床试验

NCT01590758 / Completed临床3期

A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers

The purpose of this study is to establish the clinical superiority and the safety of topical pexiganan cream 0.8% plus standard local wound care, as compared to placebo cream plus standard local wound care, in the treatment of mildly infected diabetic foot ulcers.

开始日期2014-06-01

申办/合作机构

Dipexium Pharmaceuticals, Inc.

NCT01594762 / Completed临床3期

A Randomized, Double-Blind, Multicenter, Superiority, Placebo-Controlled Phase 3 Study of Pexiganan Cream 0.8% Applied Twice Daily for 14 Days in the Treatment of Adults With Mild Infections of Diabetic Foot Ulcers

The purpose of this study is to establish the clinical superiority and the safety of topical pexiganan cream 0.8% plus standard local wound care as compared to placebo cream plus standard local wound care, in the treatment of mildly infected diabetic foot ulcers.

开始日期2014-06-01

申办/合作机构

Dipexium Pharmaceuticals, Inc.

100 项与 Dipexium Pharmaceuticals, Inc. 相关的临床结果

登录后查看更多信息

0 项与 Dipexium Pharmaceuticals, Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 Dipexium Pharmaceuticals, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Dipexium Pharmaceuticals, Inc. 相关的转化医学

登录后查看更多信息